Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRAVITI PHARMS

  • FDA Approval
  • Sept. 17, 2024, 05:31 UTC
  • 43
  • 0 comments

FDA approve CYCLOBENZAPRINE HYDROCHLORIDE

Comment Full text

ELI LILLY AND CO

  • FDA Approval
  • Sept. 16, 2024, 11:31 UTC
  • 44
  • 0 comments

FDA approve LEBRIKIZUMAB-LBKZ

Comment Full text

BIOGEN INC

  • FDA Approval
  • Sept. 16, 2024, 11:11 UTC
  • 43
  • 0 comments

FDA approve DIROXIMEL FUMARATE

Comment Full text

ANI PHARMS

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 39
  • 0 comments

FDA approve CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Comment Full text

RISING

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 39
  • 0 comments

FDA approve CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 44
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 45
  • 0 comments

FDA approve METHOTREXATE

Comment Full text

HERITAGE LIFE

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 44
  • 0 comments

FDA approve CLOZAPINE

Comment Full text

J AND J CONSUMER INC

  • FDA Approval
  • Sept. 16, 2024, 08:47 UTC
  • 43
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 354
  • 355
  • 356
  • 357
  • 358
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216339)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137521)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin